Hinge Health, Inc.
HNGE
$55.07
-$0.94-1.68%
NYSE
06/30/2025 | |||||
---|---|---|---|---|---|
Revenue | 12.33% | ||||
Total Other Revenue | -- | ||||
Total Revenue | 12.33% | ||||
Cost of Revenue | 71.42% | ||||
Gross Profit | -1.57% | ||||
SG&A Expenses | 516.63% | ||||
Depreciation & Amortization | -- | ||||
Other Operating Expenses | -- | ||||
Total Operating Expenses | 550.26% | ||||
Operating Income | -4,520.46% | ||||
Income Before Tax | -570.91% | ||||
Income Tax Expenses | -132.67% | ||||
Earnings from Continuing Operations | -574.52% | ||||
Earnings from Discontinued Operations | -- | ||||
Extraordinary Item & Accounting Change | -- | ||||
Minority Interest in Earnings | -- | ||||
Net Income | -574.52% | ||||
EBIT | -4,520.46% | ||||
EBITDA | -4,347.58% | ||||
EPS Basic | -277.67% | ||||
Normalized Basic EPS | -1,289.13% | ||||
EPS Diluted | -277.67% | ||||
Normalized Diluted EPS | -1,289.13% | ||||
Average Basic Shares Outstanding | 167.07% | ||||
Average Diluted Shares Outstanding | 167.07% | ||||
Dividend Per Share | -- | ||||
Payout Ratio | -- |